Insider Transactions in Q3 2023 at 2seventy Bio, Inc. (TSVT)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 22
2023
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
9,312
-0.8%
|
$46,560
$5.49 P/Share
|
Aug 22
2023
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
7,031
-3.46%
|
$35,155
$5.49 P/Share
|
Aug 22
2023
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,159
-2.34%
|
$30,795
$5.49 P/Share
|
Aug 10
2023
|
Kynam Global Healthcare Master Fund, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
515,414
+1.78%
|
$2,577,070
$5.9 P/Share
|
Aug 10
2023
|
Kynam Global Healthcare Master Fund, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
86,414
+1.65%
|
$432,070
$5.96 P/Share
|
Aug 10
2023
|
Kynam Capital Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
515,414
+1.78%
|
$2,577,070
$5.9 P/Share
|
Aug 10
2023
|
Kynam Capital Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
86,414
+1.65%
|
$432,070
$5.96 P/Share
|
Aug 03
2023
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
6,906
-3.28%
|
$41,436
$6.13 P/Share
|
Aug 03
2023
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,966
-1.48%
|
$23,796
$6.13 P/Share
|
Aug 03
2023
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
9,060
-0.77%
|
$54,360
$6.13 P/Share
|